Overview
Ovarian, fallopian tube, and primary peritoneal cancers are assessed with tumour markers (CA-125, HE4), pelvic imaging, and genetic evaluation for BRCA and Lynch-associated mutations.
Treatment pathways
Care combines surgery—including interval debulking after neoadjuvant chemotherapy when appropriate—with platinum-based therapy and PARP inhibitor maintenance. Interventional radiology supports ascites drainage and treatment of isolated recurrences.
Still have questions?
Reach our care team for personalized guidance on diagnosis, treatment, and insurance.
